meis

MEIS-IN-3 is a potent MEIS inhibitor [(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-thiazol-2-yl-amine] with potential applications in cancer therapy. It exhibits high binding affinity and specificity, effectively blocking MEIS activity to inhibit tumor growth.

MEIS-IN-2 is an inhibitor of MEIS1. MEIS-IN-2 can be used in studies of cardiac regeneration and haematopoietic stem cell (HSC) regulation.

MEIS-IN-1, a potent MEIS inhibitor, induces the expansion of hematopoietic stem cells in mice and humans.

MEISi-2 is a specific MEISi inhibitor that inhibits the meis luciferase reporter gene in vitro and induces MEIS-dependent hematopoietic stem cell maintenance and self-renewal, which can be used in research areas such as cardiac injury, hematopoietic problems, bone marrow transplantation and cancer.

MEISi-2 Dihydrochloride is a useful organic compound for research related to life sciences and the catalog number is T35370.

MEISi-1 is a novel MEIS inhibitor (MEISi), significantly inhibiting MEIS-luciferase reporters in vitro and inducing murine (LSKCD34low cells) and human (CD34+, CD133+, and ALDHhi cells) HSC self-renewal ex vivo.

Meisoindigo (Natura-α) is a derivative of indigo natural, might induces apoptosis and myeloid differentiation of acute myeloid leukemia (AML).

Mammeisin is a constituent of Mammea americana.

Remeisterol is a biochemical.